Status:
COMPLETED
A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses
Lead Sponsor:
Pfizer
Conditions:
Impotence
Eligibility:
MALE
18-65 years
Phase:
PHASE2
Brief Summary
The primary aim of this study is to assess how effective PF-00592379 is in restoring penile erections in patients with erectile dysfunction. Patients will attend for 4 treatment visits where they will...
Eligibility Criteria
Inclusion
- Erectile dysfunction, previous good response to an oral treatment for erectile dysfunction.
Exclusion
- Patients with high blood pressure or certain heart conditions (e.g. angina, heart failure), regardless of whether treated or not.
- Patients on nitrates or alpha-blocker medications.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00273416
Start Date
January 1 2006
Last Update
August 24 2006
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Oslo, Norway, 0277
2
Pfizer Investigational Site
Belfast, Northern Ireland, United Kingdom, BT9 6AD